Latest News and Press Releases
Want to stay updated on the latest news?
-
MALVERN, Pa., March 27, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that data from its novel SMAC-Mimetic program will be presented during...
-
MALVERN, Pa., March 13, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that J. Kevin Buchi, President and Chief Executive Officer, is the recipient of...
-
MALVERN, Pa., Feb. 26, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that J. Kevin Buchi, President and Chief Executive Officer, will present at the...
-
MALVERN, Pa., Jan. 21, 2014 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that it has entered into a research collaboration with the Walter and Eliza Hall...
-
MALVERN, Pa., Dec. 31, 2013 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced that the underwriters for its initial public offering of common stock have...
-
MALVERN, Pa., Dec. 17, 2013 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (Nasdaq:TLOG) today announced the closing of its initial public offering of 7,150,000 shares of its common stock...
-
MALVERN, Pa., Dec. 12, 2013 (GLOBE NEWSWIRE) -- TetraLogic Pharmaceuticals Corporation (TetraLogic) today announced pricing of its initial public offering of 7,150,000 shares of its common stock at a...